Dr. Staffan Schantz is Senior Director in ‘Formulation and Process Design’ at AstraZeneca and Adjunct Professor in ‘Development of Medicines’ at University of Gothenburg with ca. 30 years of experience as a scientific leader in drug development. He has received a series of AstraZeneca awards including the ‘Scientist of the Year’ Global Medicines Development prize (2014) and the CEO Award in Science & Innovation (2025). Staffan is inventor of several patents and co-author of ca. 60 publications and he has pioneered the implementation of several experimental and theoretical methods in the pharmaceutical field to solve major structure-property challenges, e.g. in advanced drug delivery, crystal structure prediction, amorphous materials, as well as formulations and continuous manufacturing. Besides his roles in the pharmaceutical industry and the academy, he has been board member of the Swedish NMR Centre and expert member of Pharmacopeia committees, nationally as well as on the European level. Furthermore, he is engaged in several industry-academy consortia including CMAC, PANACEA (Chair of External Advisory Board and Innovation Manager), FibRe (Board member), EPFL Lausanne, and he leads the collaboration in advanced DNP-NMR technology between AstraZeneca and University of Gothenburg.
